Cancer Selectivity of Tetrabranched Neurotensin Peptides Is Generated by Simultaneous Binding to Sulfated Glycosaminoglycans and Protein Receptors-Reference-Cited by-同舟云学术

Cancer Selectivity of Tetrabranched Neurotensin Peptides Is Generated by Simultaneous Binding to Sulfated Glycosaminoglycans and Protein Receptors

Published:2013-06-06 Issue:12 Volume:56 Page:5009-5018
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Falciani Chiara¹²,Brunetti Jlenia¹,Lelli Barbara¹,Ravenni Niccolò¹,Lozzi Luisa¹,Depau Lorenzo¹,Scali Silvia¹,Bernini Andrea³,Pini Alessandro¹,Bracci Luisa¹²

Affiliation:

1. Department of Medical Biotechnologies, University of Siena, Via Fiorentina 1, 53100 Siena, Italy

2. Istituto Toscano Tumori (ITT), Via Fiorentina 1, 53100 Siena, Italy

3. Department of Biotechnology, Chemistry, and Pharmacy, University of Siena, Via Fiorentina 1, 53100 Siena, Italy

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm400329p

Reference49 articles.

1. The Vps10p-domain receptor family

2. Functional Organization of the Sortilin Vps10p Domain

3. Activation and Functional Characterization of the Mosaic Receptor SorLA/LR11

4. Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Branched Oncolytic Peptides Target HSPGs, Inhibit Metastasis, and Trigger the Release of Molecular Determinants of Immunogenic Cell Death in Pancreatic Cancer;2024-09-03

2. Synthesis, docking studies, in vitro cytotoxicity evaluation and DNA damage mechanism of new tyrosine‐based tripeptides;Journal of Biochemical and Molecular Toxicology;2023-05-27

3. The Alterations and Roles of Glycosaminoglycans in Human Diseases;Polymers;2022-11-18

4. Advances in Research on Bladder Cancer Targeting Peptides: a Review;Cell Biochemistry and Biophysics;2021-09-01

5. Therapeutic approaches targeting the neurotensin receptors;Expert Opinion on Therapeutic Patents;2021-01-08